Redeye considers Bredband2’s Q3 report to be largely in line with estimates, posting growth of 9% y/...
Redeye comments on W5 Solutions Q3-report which saw softer topline than expected while a strong gros...
* Sales in line but adj. EBIT 31% below consensus..
Redeye provides an initial take on Cheffelo’s Q3 2025 report.
* Aims to grow DTC by ~30% CAGR next three years * We lower our '26e-'27e EBITA by 3-2% on cost ramp...
* Sales SEK 23.5m as pre-announced, EBIT +5% vs. ABGSCe * 5m EE milestone pushed to '27, expect '25 ...
Redeye notes a somewhat mixed Q3, with a sales miss due to lower distributor sales (Thermo) and a we...
* +5%/+3% adj. EBITDA vs ABGSCe/Infront cons in Q3 * Cons estimates likely up 1-2% on adj.
Redeye provides an update on Scandinavian ChemoTech following the Q3 2025 report.
Redeye updates its estimates and valuation following Serstech’s Q3 2025 report.
Cargo tonnes grew by 8% and the number of passengers increased by 1.
* EBIT adj. SEK 7.2m (9.4m), vs. ABGSCe of SEK 14m * We lower '26e-'27e EBIT adj.
* Q3 beat our expectations handily, EBITA 29% above * Raise '26e-'27e EBITA 15-14% on higher margin ...
Redeye comments on the news from VGR regarding its future healthcare information environment.
Redeye provides its initial comments on BICO following its Q3 results, which came in above expectati...
Thunderful did not release any major titles during the third quarter.
Redeye comments on Freemelt’s Q3 report, which was slightly better than we expected.
Enea provided updated financial goals of an average CAGR of 10% over the next three-year period and ...
* Orders +11%, sales -7%, adj. EBITA +29% vs. ABGSCe * Strong margin due to good mix in E&E and impr...
Redeye provides an initial comment on Serstech’s Q3 2025 report.
